Exploring an independent association between rituximab-cyclophosphamide-doxorubicin-vincristine-prednisolone dose intensity and clinical outcomes in large B-cell lymphoma: Analyses of subsequent endpoints following a complete response in a real-world cohort of 1369 patients.

Umut Yılmaz, Mehmet Sinan Dal, Turgay Ulaş, Elif Birtaş Ateşoğlu, Fatma Keklik Karadağ, Meral Uluköylü Mengüç, Esra Terzi Demirsoy, Kıvanç Koruk, Ebru Pekgüç, Taner Tan, Uğur Hatipoğlu, Eda Nuhoğlu Kantarcı, Merve Apaydın Kayer, Ahmet Bahadır Ak, Serdar Örnek